19.01.2017 • NewsPeopleWeylChemconsumer care

WeylChem Appoints Gerhard Köppikus as New Sales Director Consumer Care

Gerhard Köppikus joined WeylChem on Nov. 1, 2016 as sales director consumer care. Vincent Bossert, who previously occupied this role, will leave the company in April 2017. In his new position, Köppikus will lead the commercial team located in Wiesbaden, Germany.

"Gerhard adds substantial experience in the Consumer Care industry to our team," said Andreas Maier, head of the business unit consumer care. "His combination of knowledge and sales management skills will serve him well as he takes on this new responsibility.”

Köppikus has more than 25 years of business experience from various commercial roles in the consumer goods industry. Prior to joining WeylChem he was leading Univar’s personal care business. He has an economic background and is working in the chemical industry since 2005.

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.